CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0

CUSIP: 229678AD9

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Debt / NOTE 2.500%11/0
Market price (% of par)
232.94%
Total 13F principal
$195,865,468
Principal change
-$16,224,007
Total reported market value
$456,639,513
Number of holders
35
Value change
-$38,429,565
Number of buys
12
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 229678AD9?
CUSIP 229678AD9 identifies 229678AD9 - CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 as of Q3 2014

As of 30 Sep 2014, CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 was held by 35 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $195,865,468 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, Polar Securities Inc., BlackRock Advisors LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, WHITEBOX ADVISORS LLC, ROYAL BANK OF CANADA, BlackRock Group LTD, BANK OF AMERICA CORP /DE/, DEUTSCHE BANK AG\, and Jabre Capital Partners S.A.. This page lists 35 institutional bondholders reporting positions for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.